Former President of Monsanto Canada Joins Calyx Board
January 23 2014 - 10:23AM
Marketwired
Former President of Monsanto Canada Joins Calyx Board
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan 23, 2014) -
Calyx Bio-Ventures Inc. (TSX-VENTURE:CYX) ("Calyx" or the
"Company") is pleased to announce that Derek Penner has joined the
Company's board of directors effective January 22, 2014. Mr. Penner
brings extensive global agriculture commercialization, potential
partnership relationships and executive leadership experience to
Calyx, having previously served as President of Monsanto
Canada.
Derek Penner is a world-class executive with national and
international experience in agriculture. He is a highly motivated
professional who has successfully led many functions within a
leading global agricultural biotechnology corporation and a rapidly
expanding entrepreneurial organization. As president of Monsanto
Canada Mr. Penner grew sales and profits by 30%, significantly
contributing to overall corporate wide profitability, revenue and
cash flow growth. Mr. Penner developed and rolled out a vision and
strategy for Monsanto Canada along with a restructuring plan to
guide the business into new jurisdictions. Prior to his role as
president, Mr. Penner held positions of chief financial officer of
Monsanto Canada and Director of Product Management, Strategy and
Licensing for Monsanto International. During his time with
Monsanto, he was engaged in and led a variety of business and
strategic initiatives in Europe, Middle East, Africa and Canada
including: restructuring Monsanto's business model which included
decentralization of product management and marketing functions;
divesture of product lines and production facilities; acquisitions;
and the development of market strategies for new markets in Eastern
Europe and East Africa.
"It is with great excitement that I join as a member of Calyx
Bio-Venture's Board of Directors. The development of the
proprietary crop "Carinata" is an innovation in agriculture
research that will benefit farmers and the agricultural industry
while bringing an alternative fuel to market that will reduce
carbon emissions. It is not often there is an industry game changer
that can benefit all along the value chain from the grower to the
end user of the biofuel. Calyx is a company that realizes the
importance of reaching new heights and I look forward to being part
of the team that brings a green and sustainable fuel to the world"
commented Derek.
"We are delighted to have Derek join the Calyx board. Having
previously served as President of Monsanto Canada Derek gained
unparalleled agriculture and biotechnology experience. He is an
effective leader who has monetized opportunities and executed
efficiently. His experience is vital in the commercialization of
Carinata in Western Canada and the northern United States"
commented Don Konantz, chief executive officer of Calyx."
Additionally, the company announces the resignation of Richard
Whittall from the board of directors. The Board thanks Richard for
his ongoing contributions.
About Calyx
Calyx Bio-Ventures Inc. (TSX-VENTURE:CYX) is an agricultural
technology company focused on renewable fuels including biojet and
biodiesel. Calyx is the largest shareholder of Agrisoma Biosciences
Inc., a company which is producing a new proprietary non-food
energy feedstock crop - carinata - which yields oil that can be
refined into fuels that work in existing engines as a 100 percent
petroleum substitute. From seed to sky, fuels produced from
carinata substantially reduce carbon and other harmful emissions,
and help to reduce global petroleum dependence. Carinata was used
to fly the world's first 100% biojet flight, as achievement that
Popular Science called one of the top science events on the planet
in 2012. For further information about Calyx, please visit
www.calyxbio.com. For more information on Agrisoma, please visit
www.agrisoma.com.
Forward-Looking Statements: This document contains certain
forward-looking statements concerning Calyx, as well as other
expectations, plans, goals, objectives, information or statements
about future events, conditions, or performance that may constitute
"forward-looking statements" or "forward-looking information" under
applicable securities legislation. Such statements or information
involve substantial known and unknown risks and uncertainties,
certain of which are beyond Calyx's control.
Such forward-looking statements or information are based on
a number of assumptions, which may prove to be incorrect.
Although Calyx believes that the expectations reflected in
such forward-looking statements or information are reasonable,
undue reliance should not be placed on forward-looking statements
because Calyx can give no assurance that such expectations will
prove to be correct. Forward-looking statements or information are
based on current expectations, estimates and projections that
involve a number of risks and uncertainties which could cause
actual results to differ materially from those anticipated by Calyx
and described in the forward-looking statements or
information.
The forward-looking statements or information contained in
this news release are made as of the date hereof and Calyx
undertakes no obligation to update publicly or revise any
forward-looking statements or information, whether as a result of
new information, future events or otherwise unless so required by
applicable securities laws or the TSX Venture Exchange. The
forward-looking statements or information contained in this news
release are expressly qualified by this cautionary
statement.
Neither the
TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
Calyx Bio-Ventures Inc.Don KonantzPresident &
CEO604-649-5961dkonantz@calyxbio.comInvestor Relations:Calyx
Bio-Ventures Inc.Keir
Reynolds778-998-9242kreynolds@calyxbio.comwww.calyxbio.com
Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From May 2024 to Jun 2024
Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From Jun 2023 to Jun 2024